A detailed history of Private Trust CO Na transactions in Natera, Inc. stock. As of the latest transaction made, Private Trust CO Na holds 251 shares of NTRA stock, worth $33,661. This represents 0.0% of its overall portfolio holdings.

Number of Shares
251
Previous 264 4.92%
Holding current value
$33,661
Previous $24,000 12.5%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

SELL
$85.28 - $112.6 $1,108 - $1,463
-13 Reduced 4.92%
251 $27,000
Q1 2024

Apr 24, 2024

SELL
$59.21 - $92.9 $4,914 - $7,710
-83 Reduced 23.92%
264 $24,000
Q4 2023

Jan 24, 2024

BUY
$37.55 - $62.64 $2,140 - $3,570
57 Added 19.66%
347 $21,000
Q1 2023

Apr 12, 2023

SELL
$36.57 - $58.29 $36 - $58
-1 Reduced 0.34%
290 $16,000
Q4 2022

Jan 18, 2023

BUY
$34.17 - $47.91 $649 - $910
19 Added 6.99%
291 $0
Q3 2022

Oct 17, 2022

BUY
$36.93 - $56.68 $3,508 - $5,384
95 Added 53.67%
272 $11,000
Q2 2022

Sep 16, 2022

BUY
$28.13 - $44.54 $4,979 - $7,883
177 New
177 $6,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $13B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Private Trust CO Na Portfolio

Follow Private Trust CO Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Private Trust CO Na with notifications on news.